ASSOCIATE DIRECTOR, STRATEGIC CONSULTING
In statistics, rho is a measure of correlation. I believe that work ethic and creativity have a strong, positive association with success and future opportunities. Not all health care questions can be answered with due diligence alone, but if I am unfamiliar with a challenge, I know that being thorough in my efforts and open to new approaches will allow me to complete any task. “I’m a great believer in luck, and I find the harder I work the more I have of it.” – Thomas Jefferson.
Dan Gratie is an Associated Director within Strategic Consulting.
As a consultant, Dan has partnered with industry clients to conduct comprehensive competitive landscape analyses, develop and improve payer-facing communication tools, and evaluate and creatively address potential evidence gaps in a variety of therapeutic areas, including oncology and other specialty products. Additionally, Dan draws on experiences across the product life cycle, from pipeline to post-launch positioning in the face of upcoming competitors.
Prior to joining AESARA, Dan was a Clinical Health Outcomes fellow at GlaxoSmithKline (GSK) and the University of North Carolina (UNC) after completing his PharmD. At GSK he gained experience developing evidence generation protocols, managing ongoing studies, creating communications, and contributing to value dossiers for GSK’s respiratory portfolio. Additionally, Dan has led projects at UNC involving database research and an oncology-focused systematic review.
Yawn B, McCreary G, Linnell J, Pasquale C, Malanga E, Choate R, Stempel D, Gondalia R, Kaye L, Collison K, Wu B, Gratie D, Stanford R, Tomlinson R. Patient experience with an ELLIPTA inhaler electronic medication monitor and associated integrated system: A prospective observational study using the COPD Patient-Powered Research Network. (In Development)
Mularski R, Wu B, Fuoco MJ, Moretz C, McBurnie MA, Stanford R, Crawford P, Gratie D, Salas B. Continuity of Care Assessment Within a Vertically Integrated Care Management Organization Before and After COPD-Related Exacerbations. (In Development)
Gratie D, Cook S, Urick B. “The predictive value of prescription claims as a proxy for diagnosis of diabetes.” Poster presented at Pharmacy Quality Alliance Annual Meeting, May 2019, Baltimore, MD.
Hinds D, Fairburn-Beech J, Gratie D, Averell C. “Characteristics of treated asthma patients experiencing exacerbations in a US database.” Poster presented at the American Thoracic Society Annual Meeting, May 2019, Dallas, TX.
Sleath B, Gratie D, Carpenter D, et al. Reported Problems and Adherence in Using Asthma Medications Among Adolescents and Their Caregivers. Ann Pharmacother. 2018; 52(9):855-861.
Lafata JE, Gratie D, Nguyen B, Muluneh B, Patient-clinician communication and oral chemotherapy adherence. Poster presented at the American Society of Clinical Oncology Annual Meeting, June 2018, Chicago, IL.
Areas of Expertise
- Evidence Generation Strategy
- Protocol Development and Project Management
- Health Economics and Outcomes Research
- Value Dossiers
- Competitive Landscape Analysis
- MS (pending), Applied Pharmacoeconomics, University of Florida, Gainesville, FL
- Post-doctoral fellowship, Health Outcomes, University of North Carolina, Chapel Hill, NC
- PharmD, Pharmacy, University of Illinois at Chicago, Chicago, IL
- BS, Human Physiology, University of Iowa, Iowa City, IA